Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 129 of the 162 references it cites were found in a registry or an index, and 33 are not checked yet; 18 of the 107 sources its claims cite were checked for support.

Congenital adrenal hyperplasia

Open access
El-Maouche, Diala, Arlt, Wiebke, Merke, Deborah P · 2017 · The Lancet

Abstract

Congenital adrenal hyperplasia is a group of autosomal recessive disorders encompassing enzyme deficiencies in the adrenal steroidogenesis pathway that lead to impaired cortisol biosynthesis. Depending on the type and severity of steroid block, patients can have various alterations in glucocorticoid, mineralocorticoid, and sex steroid production that require hormone replacement therapy. Presentations vary from neonatal salt wasting and atypical genitalia, to adult presentation of hirsutism and irregular menses. Screening of neonates with elevated 17-hydroxyprogesterone concentrations for classic (severe) 21-hydroxylase deficiency, the most common type of congenital adrenal hyperplasia, is in place in many countries, however cosyntropin stimulation testing might be needed to confirm the diagnosis or establish non-classic (milder) subtypes. Challenges in the treatment of congenital adrenal hyperplasia include avoidance of glucocorticoid overtreatment and control of sex hormone imbalances. Long-term complications include abnormal growth and development, adverse effects on bone and the cardiovascular system, and infertility. Novel treatments aim to reduce glucocorticoid exposure, improve excess hormone control, and mimic physiological hormone patterns.

Verified 2026-10-06 · 33 references not checked yet

Overview

CoChat Summary

TL;DR

Congenital adrenal hyperplasia (CAH) is a group of rare autosomal recessive disorders of cortisol biosynthesis, most commonly caused by 21-hydroxylase deficiency, leading to glucocorticoid/mineralocorticoid deficiency and androgen excess. This Lancet seminar reviews genetics, pathophysiology, diagnosis, management, long-term complications, and emerging therapies.

Key findings

  • CAH comprises seven autosomal recessive enzyme defects; over 95% is due to 21-hydroxylase deficiency. Classic 21OH deficiency incidence is 1:10,000 to 1:20,000, while nonclassic is about 1:1,000. Neonatal screening is performed in over 40 countries, including all 50 US states since 2009, but not yet in the UK.
  • Diagnosis of 21OH deficiency relies on 17OHP: neonatal screening uses dried blood spots; after infancy, early morning 17OHP above 1,000 ng/dL (30 nmol/L) is diagnostic, and less than 200 ng/dL (6 nmol/L) usually excludes nonclassic CAH if measured in the follicular phase. Cosyntropin stimulation is often needed for nonclassic diagnosis.
  • Management centers on chronic glucocorticoid therapy, fludrocortisone for salt-wasting forms, stress-dose glucocorticoids, and sex steroid replacement in rare forms; anti-hypertensives may be needed in 11βOH and 17OH deficiency. Genital surgery, prenatal dexamethasone, and bilateral adrenalectomy remain controversial.
  • Long-term complications include short stature (meta-analysis of 35 studies: average final height 1.38 SD below population norm in classic 21OH deficiency), excess mortality from adrenal crises in a Swedish cohort of 588 patients, testicular adrenal rest tissue in 44–94% of men and 21–33% of boys with classic 21OH deficiency, and low BMD prevalence of 37–81%. Emerging therapies include Chronocort in 16 patients, a CRF1 antagonist lowering ACTH/17OHP in 6 of 8 females, abiraterone normalizing androstenedione in 5 of 6 women, and anti-androgen/aromatase inhibition with reduced hydrocortisone normalizing growth over 2 years in 28 prepubertal children.

Methods

  • Narrative review/Lancet Seminar; no systematic search strategy, formal quality appraisal, or meta-analysis methods are described.
  • Synthesizes literature, clinical practice guidelines, cohort studies, trials, and case reports across the seven main forms of CAH: 21OH, 11βOH, 17OH, 3βHSD2, POR, lipoid CAH/StAR, and SCC/CYP11A1 deficiency.
  • Reports selected quantitative data from cited studies, including incidences, hormone cutoffs, cohort prevalences, and early-phase trial results, but presents no primary data collection or original analysis.

Limitations

  • Stated: long-term effects of prenatal dexamethasone exposure are unknown; genital surgery outcomes are imperfect, and newer surgical approaches lack long enough follow-up to assess outcomes.
  • Stated: bilateral adrenalectomy carries increased adrenal crisis risk and about one-third develop adrenal rest tissue if glucocorticoid dose is too low; many novel therapies are early-phase or small studies.
  • Evident: as a narrative seminar, it lacks systematic search and formal evidence grading, relying on cited literature and expert synthesis; some statements, such as screening implementation status, are time-sensitive.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(17)31431-9

Cites

129 of 162 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Image 1
CC-BY-NC-ND · From the PDF
Image 2
CC-BY-NC-ND · From the PDF
Image 3
CC-BY-NC-ND · From the PDF
Image 4
CC-BY-NC-ND · From the PDF
Image 5
CC-BY-NC-ND · From the PDF
Figure 3A Click here to download high resolution image
Figure 3A Click here to download high resolution imageCC-BY-NC-ND · From the PDF
Figure 3B Click here to download high resolution image
Figure 3B Click here to download high resolution imageCC-BY-NC-ND · From the PDF
Figure 3C Click here to download high resolution image
Figure 3C Click here to download high resolution imageCC-BY-NC-ND · From the PDF

Verification

Claims the paper makes

8 Valid · 7 Not valid · 58 Not checked · 21 Own results and interpretations

41 more claims · 3 with their cited sources checked

Create a free account to see all 94 claims and to verify the 89 references still open.

See all claims — free account
  • Probably not a substantial claim. 8
  • It may state two separate claims as one. 43

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

1 retracted

Show all 162 references

Research works printed but not linked: 1

  1. White, 1994, Disorders of steroid 11 beta-hydroxylase isozymes, Endocr Rev, 15, 421

Cited by

See all 701

Metadata

Authors
El-Maouche, D., Arlt, W., & Merke, D. P.
Affiliations
  • University of Birmingham (GB)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (US)
Corresponding author
Merke, Deborah P
Venue
The Lancet
Publisher
Elsevier BV
Published
2017-11
Volume
390
Issue
10108
Pages
2194-2210
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2103673171
Cited by
669
References
162
Citations by year
2026: 31 · 2025: 43 · 2024: 92 · 2023: 89 · 2022: 85 · 2021: 91 · 2020: 66 · 2019: 58 · 2018: 46 · 2017: 20
FWCI
4.87
Type
journal article
Language
en
Licence
  • cc-by-nc-nd
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by-nc-nd)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Keywords
congenital adrenal hyperplasia, 21-hydroxylase deficiency, adrenal steroidogenesis, cortisol production, hormone replacement therapy, newborn screening, 17-hydroxyprogesterone, ACTH stimulation test, salt wasting, ambiguous genitalia, hirsutism, infertility, sex hormone imbalance, late complications
MeSH terms
Adrenal Hyperplasia, Congenital, Combined Modality Therapy, Dose-Response Relationship, Drug, Female, Follow-Up Studies, Glucocorticoids, Humans, Infant, Newborn, Male, Severity of Illness Index, Neonatal Screening, Treatment Outcome, Risk Assessment, Genetic Predisposition to Disease, Hormone Replacement Therapy, Rare Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Congenital adrenal hyperplasia. https://app.cochat.ai/papers/10.1016/s0140-6736(17)31431-9
The paper
El-Maouche, D., Arlt, W., & Merke, D. P. (2017). Congenital adrenal hyperplasia. The Lancet. https://doi.org/10.1016/s0140-6736(17)31431-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.